Testing effectiveness (Phase 2)Study completedNCT04760730
What this trial is testing
Safety and Immunogenicity Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime Boost Regimen for the Prevention of Coronavirus Disease 2019 (COVID-19)
Who this might be right for
COVID-19
R-Pharm 100